Location: Home
  • search
  • go
  • Relate News
  • 3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
  • 3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • 2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...
  • 2/15/2022Snapshot of MNC Pharma's China Performance in 2021
  • 2/10/2022AstraZeneca Reports Q4 and FY 2021 Performance, China Revenue Surging ...
  • 2/9/2022GSK Reports Q4 and FY2021 Performance with China Related Mentions
  • 2/8/2022Sanofi Reports Slowing Chinese Growth in Q4/2021
  • 2/8/2022MSD's China Sales Skyrocketed Driven by Strong HPV Vaccine Growth
  • 2/8/2022Novartis China Witness 10% Innovative Medicine Sales Growth in 2021 De...
  • 2/7/2022Mybio Publishes the 2021 China Pharma BD Transactions Report
  • 1/30/2022China Issues the 14th Five Year Plan for Pharmaceutical Industry Devel...
  • 1/28/2022NMPA Suspends Import, Sales and Use of JWLS's Fat Emulsion Product in ...
  • 1/26/202293 Listed MedPharm Cos Release 2021 Performance Guidance amid Weakness
  • 1/26/2022Information Collection on the 7th VBP Initiated at Numerous Provinces
  • 1/18/2022Review of Chinese Pharmaceutical industry Performance Q1/2019-Q3/2021
  • 1/11/2022China Healthcare Stocks Post Worst Start in Six Years as Woes Deepen (...
  • 1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ
  • 1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...
  • 1/5/2022Review of Chinese Pharma In-licensing Deals in 2021
  • 1/5/2022China 2021: The NRDL Readout (PharmExec)
  • 12/28/2021SMEI Forecasts Outlook of Chinese Pharma in 2022
  • 12/27/2021China's 2021 Negative Lists Widen Market Access for Foreign Investment...
  • 12/17/2021Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...
  • 12/13/2021IQVIA: Chinese Hospital Drug Market Growth Slowed to 2.7% in Q3/2021
  • 12/13/2021Nine Observations from A Busy Few Weeks Back at the Heart of the China...
  • 11/30/2021JPO Releases Final Tender Outcome of the 6th VBP
  • 11/30/2021NH's DB6: Pandemic Continues to Dictate CHC Trends with China Recoveri...
  • Page:11/39 Total number of articles:1144: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group